Institute events
RSS feedM&M’s – Muscle Monday Seminar – 10 May – Guillaume Millet (France)
Measuring fatigability in clinical populations: is it relevant? Monday 10 May from 12 am to 1 pm Guillaume Millet, PhD (Professor at Jean Monnet University (Saint-Etienne, France), Leader of the ActiFS academic chair, Senior member of the Institut Universitaire de France 2019, Director of the inter-university Laboratory of Human Movement Biology in 2020) Hosted by Jean-Yves … [Read more]
M&M’s – Muscle Monday Seminar – 3 May – Walter Herzog (Canada)
The forgotten filament: titin’s contribution to active force production in skeletal muscle Monday 3 May from 4 to 5 pm. Dr Walter Herzog (Professor, Faculty of Kinesiology and Department of Mechanical and Manufacturing Engineering, University of Calgary, Adjunct Professor, Department of Surgery and Faculty of Veterinary Medicine, University of Calgary, Director, Human Performance Lab, Tier I … [Read more]
DMD: gene therapy clinical trial starting in France
A first patient with Duchenne muscular dystrophy has received a gene therapy treatment at I-Motion, the paediatric clinical platform for neuromuscular diseases, in the context of a clinical trial conducted by Généthon. A first decisive step! A young boy with Duchenne muscular dystrophy was treated with a gene therapy at I-Motion, in Paris. He is … [Read more]
M&M’s – Muscle Monday Seminar – 19 April – Benjamin Prosser (USA)
Microtubules in Cardiac Mechanics and Growth Monday 19 April – 2 pm-3 pm Benjamin Prosser (Assistant Professor of Physiology, Perelman School of Medicine, Philadelphia, US) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr > More information on the presentation and the speaker
M&M’s – Muscle Monday Seminar – 12 April – Sonia Alonso Martin (Spain)
Intrinsic muscle abnormalities in Amyotrophic Lateral Sclerosis Monday 12 April – 12 am-1 pm Sonia Alonso Martin, PhD (Neuromuscular Diseases Group (Neurosciences Area) at BIODONOSTIA HRI (Donostia/San Sebastián, Spain). Research Fellow – Gipuzkoa Fellows Program for Talent Attraction and Retention) Invited by Maria-Grazia Biferi and Capucine Trollet On prior registration for people outside the Institute … [Read more]
SMA-PAR, a study of the parenthood experience of parents of children with SMA conducted by Sophie Boursange
Sophie Boursange, psychologist at I-Motion, is currently carrying out research in human and social sciences within the department, under the supervision of Prof. M. Gargiulo, clinical psychologist and Professor of psychology at the University of Paris. This research aims to describe the subjective experience of parents and to analyze the impact of the disease on … [Read more]
The institute is recruiting a Clinical Research Physician
Located in Paris in the heart of the largest European hospital, the Pitié-Salpêtrière, the Institute of Myology was created in 1996 by AFM-Téléthon, a patient’s organization. Its objective is to promote the recognition and development of myology as a standalone clinical and scientific discipline. The Institute of Myology coordinates, around the patient, medical care, basic … [Read more]
M&M’s – Muscle Monday Seminar – 29 March – R. Jude Samulski (USA)
AAV Gene Therapy for Duchenne Muscular Dystrophy- a 25 Year Journey Monday 29 March 2021 – 16:00-17:00 Prof. R. Jude Samulski (UNC School of Medicine, Department of Pharmacology, Professor – President, Chief Scientific Officer and Co-Founder of Askbio) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr > Further details on the seminar … [Read more]
ERN EURO-NMD webinar, 1 April: Melanie Quintana
Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN Thursday 1 April 2021 – 4:00 am (Paris time) Modeling disease progression in GNE myopathy Melanie Quintana, PhD, Senior Statistical Scientist at Berry Consultants You may register here: https://aim.zoom.us/webinar/register/WN_5LBXfwhxTVydKwnbjhc6Iw
Muscular dystrophies with collagen-VI deficiency: predictive indices of the long-term phenotype?
Collagen VI myopathies (or collagenopathies VI) represent a group of muscular dystrophies whose clinical expression ranges from severe and early forms of infancy (congenital muscular dystrophy of Ullrich) to relatively benign forms ( Bethlem myopathy, LGMD R22 or D5), passing through many intermediate forms. The collagen VI deficiency, a key protein of the extracellular matrix, … [Read more]
